Navigation Links
Prometheus Laboratories Appoints Chief Executive Officer
Date:9/19/2013

SAN DIEGO, Sept. 19, 2013 /PRNewswire/ -- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company announced today that Ms. Lisa Miller has been appointed to the position of Chief Executive Officer.

With more than 25 years of experience in the global diagnostic and devices industries, Ms. Miller most recently served as Corporate Vice President at DAKO, an Agilent Technologies Company, headquartered in Copenhagen, Denmark. She was responsible for global operations of their cancer diagnostics business, with $375M in revenue and over 500 employees worldwide. She was also a member of the Board of Directors and Corporate Management Team. Under her leadership, Ms. Miller redefined DAKO's strategy and restructured the commercial operations of the company, resulting in its 2012 acquisition by Agilent Technologies.

Prior to joining DAKO, Ms. Miller was with Invitrogen Corporation, in the position of Vice President, Commercial Business and head of the Americas region. Prior to this, she held several positions of increasing commercial responsibility at Thermo Fisher Scientific, most recently as Vice President Sales with accountability for a $600M business. During her tenure at Thermo Fisher, Ms. Miller held several senior sales and account management positions focused on growth and business development through contractual relationships with major pharmaceutical companies.

Ms. Miller commented: "I am very enthusiastic about joining Prometheus to drive our diagnostic strategy across the chosen therapeutic platforms. I believe Prometheus plays a key role in Nestle Health Science's ambition to create a new segment in health care, using diagnostic and nutrition science solutions in the management of disease."

"We are delighted to have Ms. Miller join our team," commented Cathy Kerzner, interim CEO of Prometheus. "We anticipate she will make a tremendous contribution to our growth strategy, with her depth in diagnostics along with her proven record of performance.'

About Prometheus
Prometheus Laboratories Inc. is committed to improving lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. Prometheus is a leader in applying the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and is applying these principles to oncology. Its strategy includes the marketing and delivery of pharmaceutical products complemented by proprietary diagnostic testing services. By integrating therapeutics and diagnostics, Prometheus believes it can provide physicians with more targeted solutions to optimize care for their patients. Prometheus became part of Nestle Health Science in July 2011. The corporate offices of Prometheus are located in San Diego, California. For more information about Prometheus, please visit www.prometheuslabs.com.

About Nestle Health Science
Nestle Health Science, a wholly-owned subsidiary of Nestle, intends to spearhead the development of science-based personalised nutritional solutions. Building on its core HealthCare Nutrition business, the company has ambitions to address chronic conditions in the area of Gastrointestinal Health, Metabolic Health and Brain Health. Nestle Health Science offers nutritional solutions for people with specific dietary needs related to illnesses, disease states or the special challenges of different life stages. Nestle Health Science employs around 3,000 people worldwide and has its headquarters in Vevey, Switzerland.For more information, please visit www.nestlehealthscience.com.


'/>"/>
SOURCE Prometheus Laboratories Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Data Support Role of Prometheus Laboratories Novel Assay in Optimizing IBD Treatment Management
2. Prometheus Launches New Monitoring Test To Help Guide Inflammatory Bowel Disease Management
3. Prometheus Launches New Adalimumab Drug And Antibody Levels Monitoring Test
4. Ameritox Files Amended Complaint Against Millennium Laboratories For Injunctive Relief, Declaratory Relief and Damages
5. Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences
6. Grant & Eisenhofer Represents Lead Whistleblower in Historic $1.6 Billion Settlement with Abbott Laboratories Over Off-Label Marketing of Antiepileptic Medication Depakote
7. Dave Zitnak Of Upsher-Smith Laboratories Named Branded Representative Of The Year By McKesson Corporation
8. Everett Laboratories, Inc. Files Patent Infringement Lawsuit Against Competitor Trigen Laboratories, Inc.
9. PeaceHealth Laboratories New Patent Addresses a Leading Cause of Death: Prescription Drug Abuse
10. Omega Laboratories Applauds the Adoption of Enzyme Immunoassay (EIA) by Major Hair Testing Laboratories
11. Court Preliminarily Deems Millennium Laboratories Press Release Misleading
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2016)... YORK , December 2, 2016 ... the trading session in red, while the Dow Jones Industrial ... at the close of US markets, which prompted Stock-callers this ... stocks: NuVasive Inc. (NASDAQ: NUVA ), Smith & ... (NASDAQ: NXTM ), and Cesca Therapeutics Inc. (NASDAQ: ...
(Date:12/2/2016)... OLD LYME, Conn. , Dec. 1, 2016 /PRNewswire/ ... consulting, has announced the honor of being selected as ... that include: Simpson Healthcare Executives Website at the PLATINUM ... Directed Conversations Training Module at the GOLD Level, and ... At Simpson Healthcare Executives, we are ...
(Date:12/2/2016)... Allergan plc (NYSE: AGN ), a ... previously announced Accelerated Share Repurchase (ASR) Program. Logo - ... ... previously announced, the Company entered into a variable tenor ASR ... repurchase $10 billion of its ordinary shares. Approximately 40.5 million ...
Breaking Medicine Technology:
(Date:12/2/2016)... ... December 02, 2016 , ... Mediaplanet’s newest campaign, “Digestive Heath,” ... living proof that attitude and determination can combine into the most remarkable achievements. ... the holidays. This campaign will offer patients a new-found hope, by seizing the ...
(Date:12/2/2016)... ... December 02, 2016 , ... ... Regency Waikiki Beach Resort and Spa in Honolulu, offering local frontline clinicians the ... pain management. , The demand for supplemental training related to pain management ...
(Date:12/2/2016)... ... December 02, 2016 , ... "Pro3rd Accents Volume 2 is a set ... lower third titles with just a few clicks of the mouse," said Christina Austin ... lower third animations. Choose from various styles with accented animations, rigid boxes, simplistic lines, ...
(Date:12/2/2016)... ... December 02, 2016 , ... ‘Tis the season for giving! Today, 20 creative ... National Family Partnership and the Drug Enforcement Administration as part of the National Red ... 10 winning schools who decorated their campuses with this year’s Red Ribbon Week theme: ...
(Date:11/30/2016)... Gardens, FL (PRWEB) , ... November 30, 2016 ... ... eating disorder and mental health treatment has announced the opening of a new ... specialized partial hospitalization and intensive outpatient treatment for adults and adolescents, both males ...
Breaking Medicine News(10 mins):